←
FDA Medical Devices8,273 posts
FDA Medical Devices avatar

FDA Medical Devices

@FDADevices

Official FDA - device recalls, safety, authorizations, radiation-emitting products. Contact us DICE@fda.hhs.gov or 800-638-2041 fda.gov/privacy

◷ Joined May 2010▧ 2,121 Photos and videos
FDA Medical Devices avatar
FDA Medical Devices@FDADevices·23h

Reminder: The FDA is hosting an advisory committee meeting on Nov. 19 for the Microbiology Devices Panel of the Medical Devices Advisory Committee. The meeting will be open to the public. Access the meeting materials and learn how to participate: fda.gov/advisory-committees/…

Post attachment
FDA Medical Devices avatar
FDA Medical Devices@FDADevices·Nov 6

The FDA is advancing the discussion on robotic medical devices. Our new discussion paper on evaluating benefit-risk in robotic devices with autonomous or remote teleoperation capabilities is now open for public comment. Submit comments here: fda.gov/medical-devices/robo…

Post attachment
U.S. FDA avatar
⟳ FDA Medical Devices retweeted
U.S. FDA@FDA·Oct 22

The FDA is launching the Neuroscience Advancement and Innovation Nexus (NAIN), a new cross-center program to advance medical products for conditions affecting the brain and nervous system. fda.gov/news-events/press-an…

Post attachment
FDA Medical Devices avatar
FDA Medical Devices@FDADevices·Oct 20

The FDA is providing resources to medical device manufacturers on Predetermined Change Control Plans (PCCPs). Manufacturers may submit a PCCP as part of a device marketing submission and, following FDA authorization, implement planned device modifications without a new marketing submission for each change as long as the changes are included in and implemented in accordance with the authorized PCCP. fda.gov/medical-devices/prem…

Post attachment
FDA Medical Devices avatar
FDA Medical Devices@FDADevices·Oct 15

The FDA and @FocusedUltrasound are co-hosting a public workshop on transcranial ultrasound for neurological and psychiatric applications on Nov. 10, 2026, in McLean, VA (hybrid). Topics include neuromodulation, blood-brain barrier (BBB) opening, safety considerations, clinical trial design and outcomes, nonclinical assessments, and pediatric considerations. Attend in-person or virtually. Register by Nov. 5: fda.gov/news-events/fda-meet…

Post attachment
FDA Medical Devices avatar
FDA Medical Devices@FDADevices·Oct 8

Don't miss this! Register today for the FDA Grand Rounds on Oct. 22. CDRH experts will take you inside FDA's Real-World Evidence Program & its role in digital health technology. Attend in person or tune in via webcast. FDA.gov/GrandRounds

Post attachment
FDA Medical Devices avatar
FDA Medical Devices@FDADevices·Oct 2

Join us for FDA Grand Rounds on Oct 22. Learn about CDRH’s Real-World Evidence (RWE) Program & how it applies to digital health technology. Hear from CDRH experts & gain practical insight into how the RWE Program could support evidence generation. This event will be offered in a hybrid format, with options to attend in person at the FDA White Oak Campus or virtually via webcast. FDA.gov/GrandRounds

Post attachment
U.S. FDA avatar
⟳ FDA Medical Devices retweeted
U.S. FDA@FDA·Oct 1

Today, we approved the first heart valve device designed to grow with children. The Autus Size-Adjustable Valve, a surgically implanted pulmonary heart valve for pediatric patients with congenital pulmonary valve disease can be expanded after surgery to keep pace with growth. The adjustable valve may mean fewer repeat surgeries for children as they get older. fda.gov/news-events/press-an… Congenital heart defects are among the most common types of birth defects in the United States, affecting about 1 in every 100 births. The valve was approved through the premarket approval pathway, the FDA's most rigorous review process for medical devices.

Post attachment
FDA Medical Devices avatar
FDA Medical Devices@FDADevices·Sep 24

Join the FDA for a public workshop: Evaluating Benefit-Risk in Robotic Medical Devices with Autonomous or Remote Teleoperation Capabilities — Dec. 2–3, 2026. Topics span surgical & non-surgical robotic medical devices, both inside and outside the OR. Workshop materials will be posted on the registration page when available. Register to attend: fda.gov/medical-devices/prod…

Post attachment
FDA Medical Devices avatar
FDA Medical Devices@FDADevices·Sep 24

The FDA has issued a draft guidance: Robotically-Assisted Surgical Devices — Premarket Submissions. The guidance, when finalized, will help manufacturers understand what safety & effectiveness information to include in premarket submissions for these devices. Submit comments by Nov. 24, 2026: fda.gov/regulatory-informati…

Post attachment
FDA Medical Devices avatar
⟳ FDA Medical Devices retweeted
FDA Medical Devices@FDADevices·Sep 21

The FDA posted materials for the upcoming Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee (the Committee) meeting on September 23, 2026. Access the meeting materials and webcast link. The Committee will discuss GRAIL Inc.’s Galleri® test premarket approval application. The Galleri® test is a prescription-only qualitative next-generation sequencing-based in vitro diagnostic blood test intended for screening for the early detection of multiple types of cancer in adults aged 50 years or older: fda.gov/advisory-committees/…

Post attachment
FDA Medical Devices avatar
FDA Medical Devices@FDADevices·Sep 18

During public health emergencies, the FDA’s Center for Devices and Radiological Health supports the development and evaluation of critical medical countermeasures to address emerging threats and meet urgent public health needs. Emergencies can happen at any time. Taking a few steps now can help you stay safe and keep  your medical devices working when you need them most. fda.gov/emergency-preparedne… #NationalPreparednessMonth

Post attachment
FDA Medical Devices avatar
FDA Medical Devices@FDADevices·Sep 15

Mark your calendars: The FDA will hold a public meeting on Nov. 19 of the Microbiology Devices Panel of the Medical Devices Advisory Committee. The Committee will meet to discuss and provide recommendations to the Agency on the use of pathogen-agnostic sequencing for emergency preparedness and response efforts. A public docket is open. Learn more and submit comments: fda.gov/advisory-committees/…

Post attachment